Clinical trial
Validation of Novel Predictive Score for Patients With Spinal Metastases
NCT03224650 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Novel Predictive Score for Patients With Spinal Metastases
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- January 31, 2022
- Enrollment
- 219 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal metastases